Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 6.61B 984M 852M 806M 729M 1.37B 94.35B 1.38B 9.61B 3.7B 47.84B 3.69B 3.61B 153B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 4.11B 612M 531M 502M 454M 852M 58.75B 859M 5.99B 2.3B 29.79B 2.3B 2.25B 95B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-1.14%
1 week-3.83%
Current month-4.88%
1 month-16.28%
3 months-9.08%
6 months-10.87%
Current year-23.43%
1 week 11.3
Extreme 11.3
11.81
1 month 11.3
Extreme 11.3
13.74
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
15.93
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 58 09/02/2026
Director of Finance/CFO 49 06/12/2021
Corporate Officer/Principal 56 20/03/2025
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
17/7/24 Buy 500 0.0001%
22/1/20 Sell

Director

246,300 0.0462%
1/1/20 Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-3.83%-27.92%-51.79% 995M
-0.04%+0.34%-13.99%-4.96% 13.49B
-1.06%-3.52%-33.71%-57.07% 4.82B
-0.77%-2.43%-5.28%-6.22% 4.42B
-1.17%-3.55%-11.63%-31.65% 3.83B
-1.59%-3.97%-26.63%-0.93% 3.43B
+0.75%-0.54%-1.23%-1.73% 3.49B
-0.29%-4.45%-14.03%+3.10% 3.12B
-0.07%-1.35%-23.83%-17.64% 2.3B
-1.29%-4.07%-30.67%-21.33% 1.63B
Average -0.67%-2.24%-18.89%-19.02% 4.15B
Weighted average by Cap. -0.50%-1.44%-16.64%-14.86%

Financials

2024 2025
Net sales 3.38B 503M 436M 412M 373M 700M 48.24B 705M 4.92B 1.89B 24.46B 1.89B 1.85B 78.01B 2.32B 345M 299M 283M 256M 480M 33.11B 484M 3.37B 1.3B 16.79B 1.3B 1.27B 53.54B
Net income 492M 73.27M 63.47M 60.02M 54.33M 102M 7.03B 103M 716M 276M 3.56B 275M 269M 11.37B -258M -38.39M -33.26M -31.45M -28.47M -53.43M -3.68B -53.84M -375M -144M -1.87B -144M -141M -5.96B
Net Debt -2.29B -341M -295M -279M -253M -474M -32.7B -478M -3.33B -1.28B -16.58B -1.28B -1.25B -52.89B -2.49B -371M -321M -304M -275M -516M -35.6B -520M -3.63B -1.4B -18.05B -1.39B -1.36B -57.57B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
15/09/26 CNY 11.31 -1.14% 2,869,499
14/09/26 CNY 11.44 +0.09% 3,696,100
11/09/26 CNY 11.43 -1.21% 3,397,729
10/09/26 CNY 11.57 -1.11% 4,208,184
09/09/26 CNY 11.70 -1.10% 3,802,015

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!